<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Med Biol Res</journal-id><journal-id journal-id-type="iso-abbrev">Braz. J. Med. Biol. Res</journal-id><journal-title-group><journal-title>Brazilian Journal of Medical and Biological Research</journal-title></journal-title-group><issn pub-type="ppub">0100-879X</issn><issn pub-type="epub">1414-431X</issn><publisher><publisher-name>Associação Brasileira de Divulgação Científica</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24554040</article-id><article-id pub-id-type="pmc">3982948</article-id><article-id pub-id-type="doi">10.1590/1414-431X20133278</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Investigation</subject></subj-group></article-categories><title-group><article-title>Application of continuous positive airway pressure in the delivery room: a multicenter randomized clinical trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gonçalves-Ferri</surname><given-names>W.A.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Martinez</surname><given-names>F.E.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Caldas</surname><given-names>J.P.S.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Marba</surname><given-names>S.T.M.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Fekete</surname><given-names>S.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Rugolo</surname><given-names>L.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Tanuri</surname><given-names>C.</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Leone</surname><given-names>C.</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Sancho</surname><given-names>G.A.</given-names></name><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Almeida</surname><given-names>M.F.B.</given-names></name><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Guinsburg</surname><given-names>R.</given-names></name><xref ref-type="aff" rid="aff6">6</xref></contrib><aff id="aff1"><label>1</label>
Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Pediatria, Ribeirão Preto, SP, Brasil, Departamento de Pediatria, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil</aff><aff id="aff2"><label>2</label>
Universidade Estadual de Campinas, Departamento de Pediatria, Campinas, SP, Brasil, Departamento de Pediatria, Universidade Estadual de Campinas, Campinas, SP, Brasil</aff><aff id="aff3"><label>3</label>
Universidade Estadual de São Paulo, Departamento de Pediatria, Botucatu, SP, Brasil, Departamento de Pediatria, Universidade Estadual de São Paulo, Botucatu, SP, Brasil</aff><aff id="aff4"><label>4</label>
Maternidade Hospital Cachoeirinha, São Paulo, SP, Brasil, Maternidade Hospital Cachoeirinha, São Paulo, SP, Brasil</aff><aff id="aff5"><label>5</label>
Universidade de São Paulo, Departamento de Pediatria, SP, Brasil, Departamento de Pediatria, Universidade de São Paulo, SP, Brasil</aff><aff id="aff6"><label>6</label>
Universidade Federal de São Paulo, Departamento de Pediatria, São Paulo, SP, Brasil, Departamento de Pediatria, Universidade Federal de São Paulo, São Paulo, SP, Brasil</aff></contrib-group><author-notes><corresp>Correspondence: W.A. Gonçalves-Ferri, Departamento de Pediatria, Faculdade de Medicina de Ribeirão Preto, USP, Av. Bandeirantes, 3900, 14049-900 Ribeirão Preto, SP, Brasil, +55-16-3602-2700. E-mail: <email>walusa3@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>03</day><month>3</month><year>2014</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2014</year></pub-date><volume>47</volume><issue>3</issue><fpage>259</fpage><lpage>264</lpage><history><date date-type="received"><day>5</day><month>6</month><year>2013</year></date><date date-type="accepted"><day>4</day><month>11</month><year>2013</year></date></history><abstract><p><offsets xml_i="4714" xml_f="5743" txt_i="11" txt_f="1040">This study evaluated whether the use of continuous positive airway pressure (CPAP) in the delivery room alters the need for mechanical ventilation and surfactant during the first 5 days of life and modifies the incidence of respiratory morbidity and mortality during the hospital stay. The study was a multicenter randomized clinical trial conducted in five public university hospitals in Brazil, from June 2008 to December 2009. Participants were 197 infants with birth weight of 1000-1500 g and without major birth defects. They were treated according to the guidelines of the American Academy of Pediatrics (APP). Infants not intubated or extubated less than 15 min after birth were randomized for two treatments, routine or CPAP, and were followed until hospital discharge. The routine (n=99) and CPAP (n=98) infants studied presented no statistically significant differences regarding birth characteristics, complications during the prenatal period, the need for mechanical ventilation during the first 5 days of life (19.2 </offsets><italic><offsets xml_i="5751" xml_f="5753" txt_i="1040" txt_f="1042">vs</offsets></italic><offsets xml_i="5762" xml_f="5803" txt_i="1042" txt_f="1083"> 23.4%, P=0.50), use of surfactant (18.2 </offsets><italic><offsets xml_i="5811" xml_f="5813" txt_i="1083" txt_f="1085">vs</offsets></italic><offsets xml_i="5822" xml_f="5963" txt_i="1085" txt_f="1226"> 17.3% P=0.92), or respiratory morbidity and mortality until discharge. The CPAP group required a greater number of doses of surfactant (1.5 </offsets><italic><offsets xml_i="5971" xml_f="5973" txt_i="1226" txt_f="1228">vs</offsets></italic><offsets xml_i="5982" xml_f="6349" txt_i="1228" txt_f="1595"> 1.0, P=0.02). When CPAP was applied to the routine group, it was installed within a median time of 30 min. We found that CPAP applied less than 15 min after birth was not able to reduce the need for ventilator support and was associated with a higher number of doses of surfactant when compared to CPAP applied as clinically indicated within a median time of 30 min.</offsets></p></abstract><kwd-group><kwd>Continuous positive airway pressure (CPAP) ventilation</kwd><kwd>Preterm infants</kwd><kwd>Delivery room</kwd><kwd>Nasal CPAP</kwd><kwd>Prematurity</kwd></kwd-group><counts><fig-count count="0"></fig-count><table-count count="3"></table-count><ref-count count="23"></ref-count><page-count count="6"></page-count></counts></article-meta></front><body><sec sec-type="intro"><title><offsets xml_i="6759" xml_f="6771" txt_i="1603" txt_f="1615">Introduction</offsets></title><p><offsets xml_i="6782" xml_f="7030" txt_i="1616" txt_f="1864">Prematurity has a great impact on health indicators. In Brazil, according to official reports, premature infants weighing less than 1500 g represented 31.6% of infant mortality cases in the country and 41.1% of the cases of early infant mortality (</offsets><xref rid="B01" ref-type="bibr"><offsets xml_i="7062" xml_f="7063" txt_i="1864" txt_f="1865">1</offsets></xref><offsets xml_i="7070" xml_f="7072" txt_i="1865" txt_f="1867">).</offsets></p><p><offsets xml_i="7079" xml_f="7421" txt_i="1868" txt_f="2210">Diseases involving the respiratory apparatus are the most important incurrences during the neonatal period, especially among preterm patients. In preterm infants, both immature development of the airways and chest and limited surfactant secretion result in a strong tendency to lung collapse with restriction of residual functional capacity (</offsets><xref rid="B02" ref-type="bibr"><offsets xml_i="7453" xml_f="7454" txt_i="2210" txt_f="2211">2</offsets></xref><offsets xml_i="7461" xml_f="7463" txt_i="2211" txt_f="2213">).</offsets></p><p><offsets xml_i="7470" xml_f="7644" txt_i="2214" txt_f="2388">In an attempt to prevent the injuries caused by mechanical ventilation, there has been a search for less aggressive ways of promoting respiratory support for these patients (</offsets><xref rid="B03" ref-type="bibr"><offsets xml_i="7676" xml_f="7677" txt_i="2388" txt_f="2389">3</offsets></xref><offsets xml_i="7684" xml_f="7685" txt_i="2389" txt_f="2390">,</offsets><xref rid="B04" ref-type="bibr"><offsets xml_i="7717" xml_f="7718" txt_i="2390" txt_f="2391">4</offsets></xref><offsets xml_i="7725" xml_f="8104" txt_i="2391" txt_f="2770">). The use of continuous positive airway pressure (CPAP) has been pointed out as a suitable option to prevent loss of pulmonary volume and to minimize the use of mechanical ventilation and of surfactant. In theory, the earlier that CPAP is applied, the lower the tendency for loss of residual functional capacity, and the easier the respiratory stabilization of preterm infants (</offsets><xref rid="B05" ref-type="bibr"><offsets xml_i="8136" xml_f="8137" txt_i="2770" txt_f="2771">5</offsets></xref><offsets xml_i="8144" xml_f="8145" txt_i="2771" txt_f="2772">,</offsets><xref rid="B06" ref-type="bibr"><offsets xml_i="8177" xml_f="8178" txt_i="2772" txt_f="2773">6</offsets></xref><offsets xml_i="8185" xml_f="8242" txt_i="2773" txt_f="2830">). However, results obtained thus far are contradictory (</offsets><xref rid="B07" ref-type="bibr"><offsets xml_i="8274" xml_f="8275" txt_i="2830" txt_f="2831">7</offsets></xref><offsets xml_i="8282" xml_f="8283" txt_i="2831" txt_f="2832">,</offsets><xref rid="B08" ref-type="bibr"><offsets xml_i="8315" xml_f="8316" txt_i="2832" txt_f="2833">8</offsets></xref><offsets xml_i="8323" xml_f="8454" txt_i="2833" txt_f="2964">) and suggest that success of this method is related to the type of assisted population and to the experience of the medical team (</offsets><xref rid="B09" ref-type="bibr"><offsets xml_i="8486" xml_f="8487" txt_i="2964" txt_f="2965">9</offsets></xref><offsets xml_i="8494" xml_f="8495" txt_i="2965" txt_f="2966">-</offsets><xref rid="B12" ref-type="bibr"><offsets xml_i="8527" xml_f="8529" txt_i="2966" txt_f="2968">12</offsets></xref><offsets xml_i="8536" xml_f="8538" txt_i="2968" txt_f="2970">).</offsets></p><p><offsets xml_i="8545" xml_f="8934" txt_i="2971" txt_f="3360">Thus, the objective of the present study was to assess the efficacy and repercussions of CPAP applied early to newborn infants weighing 1000 to 1500 g. The hypothesis raised is that the early use of CPAP reduces the need for mechanical ventilation and surfactant during the first 5 days of life, leading to a lower incidence of respiratory morbidity and mortality during the hospital stay.</offsets></p></sec><sec sec-type="materials|methods"><title><offsets xml_i="8985" xml_f="9005" txt_i="3362" txt_f="3382">Material and Methods</offsets></title><p><offsets xml_i="9016" xml_f="9283" txt_i="3383" txt_f="3650">A prospective randomized clinical study was conducted at five public university hospitals from June 2008 to December 2009. The protocol was approved by the Ethics Committees of the institutions (No. 3866/2005) and registered at ClinicalTrials.gov.br (ID NCT01024361).</offsets></p><p><offsets xml_i="9290" xml_f="9661" txt_i="3651" txt_f="4022">All premature newborns with a birth weight of 1000 to 1500 g without major malformations were considered eligible for the study, independent of gestational age. Parents gave written informed consent for participation before the infant's birth. Infants with major congenital anomalies or fetal hydrops diagnosed after birth were excluded. Only the first twin was included.</offsets></p><p><offsets xml_i="9668" xml_f="9841" txt_i="4023" txt_f="4196">Patients received support from the local neonatology team according to the 2005 guidelines of the American Academy of Pediatrics (AAP) and American Heart Association (AHA) (</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="9873" xml_f="9875" txt_i="4196" txt_f="4198">13</offsets></xref><offsets xml_i="9882" xml_f="9884" txt_i="4198" txt_f="4200">).</offsets></p><p><offsets xml_i="9891" xml_f="10371" txt_i="4201" txt_f="4677">Immediately after birth, infants were placed in a porous plastic bag, the airways were aspirated, and heart rate, respiratory effort, and color were evaluated. When the heart rate was lower than 100 bpm or the patient did not show rhythmic and regular spontaneous breathing, ventilation was maintained with a manual ventilator and mask (Neopuff™ Infant Resuscitator, Fisher &amp; Paykel Healthcare Corporation Limited, New Zealand), for 30 s, and the patient was then reevaluated.</offsets></p><p><offsets xml_i="10378" xml_f="10564" txt_i="4678" txt_f="4864">If the patient continued to be in apnea or to breathe irregularly, he was intubated and ventilated with a Neopuff™ manual ventilator with positive end-expiratory pressure (PEEP) at 5 cmH</offsets><sub><offsets xml_i="10569" xml_f="10570" txt_i="4864" txt_f="4865">2</offsets></sub><offsets xml_i="10576" xml_f="10858" txt_i="4865" txt_f="5147">O and with inspiratory pressure sufficient to obtain a maximum thoracic insufflation of 0.5 cm, a frequency of 40 movements per minute, and 100% oxygen. If the newborn established spontaneous rhythmic respiration within less than 15 min, he was extubated and eligible for the study.</offsets></p><p><offsets xml_i="10865" xml_f="11155" txt_i="5148" txt_f="5438">Infants not intubated or extubated less than 15 min after birth were randomized for two treatments: routine or CPAP. When an infant randomized for routine treatment presented central cyanosis, oxygen was started according to the techniques recommended by the guidelines of the AAP and AHA (</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="11187" xml_f="11189" txt_i="5438" txt_f="5440">13</offsets></xref><offsets xml_i="11196" xml_f="11307" txt_i="5440" txt_f="5551">). When randomized to CPAP, positive pressure was applied using a Neopuff™ manual ventilator with PEEP at 5 cmH</offsets><sub><offsets xml_i="11312" xml_f="11313" txt_i="5551" txt_f="5552">2</offsets></sub><offsets xml_i="11319" xml_f="11557" txt_i="5552" txt_f="5790">O and 100% oxygen. Newborns were transferred to the Neonatal Intensive Care Unit, where, after stabilization, ventilation parameters followed institutional protocols. The CPAP group was maintained with positive pressure for at least 48 h.</offsets></p><p><offsets xml_i="11564" xml_f="11780" txt_i="5791" txt_f="6007">Randomization was performed previously for two weight strata (1000-1250 and 1251-1500 g) in blocks of four for CPAP treatment or routine treatment in a 1:1 ratio, and the cards were placed in opaque sealed envelopes.</offsets></p><p><offsets xml_i="11787" xml_f="12067" txt_i="6008" txt_f="6288">The maternal variables evaluated were: age, number of prenatal visits, time since rupture of the membranes, gestational hypertension, diabetes, and use of an antenatal corticoid (any dose). The neonatal variables were: birth weight, gestational age, adequacy for gestational age (</offsets><xref rid="B14" ref-type="bibr"><offsets xml_i="12099" xml_f="12101" txt_i="6288" txt_f="6290">14</offsets></xref><offsets xml_i="12108" xml_f="12235" txt_i="6290" txt_f="6417">), gender, use of mask ventilation in the delivery room, intubation in the delivery room, need for cardiac massage, SNAPPE-II (</offsets><xref rid="B15" ref-type="bibr"><offsets xml_i="12267" xml_f="12269" txt_i="6417" txt_f="6419">15</offsets></xref><offsets xml_i="12276" xml_f="12518" txt_i="6419" txt_f="6661">), first- and fifth-minute Apgar score, and other intercurrences observed during hospitalization such as apnea, pneumonia, pulmonary hemorrhage, pneumothorax, atelectasis, the need for mechanical ventilation, surfactant and oxygen, and death.</offsets></p><p><offsets xml_i="12525" xml_f="12747" txt_i="6662" txt_f="6884">The primary end points were the need for mechanical ventilation and/or surfactant during the first 5 days of life, and secondary outcomes were the incidences of respiratory morbidity and mortality during the hospital stay.</offsets></p><p><offsets xml_i="12754" xml_f="13050" txt_i="6885" txt_f="7181">Sample size was calculated as 98 infants per group, based on the supposition that intervention would lead to a 20% reduction in the rates of mechanical ventilation, with a two-tailed type I error of 0.05 and 80% power. Continuous variables with a normal distribution were analyzed by the Student </offsets><italic><offsets xml_i="13058" xml_f="13059" txt_i="7181" txt_f="7182">t</offsets></italic><offsets xml_i="13068" xml_f="13220" txt_i="7182" txt_f="7334">-test, and variables without a normal distribution were analyzed by the Mann-Whitney test. Qualitative variables were analyzed by the Fisher exact test.</offsets></p></sec><sec sec-type="results"><title><offsets xml_i="13261" xml_f="13268" txt_i="7336" txt_f="7343">Results</offsets></title><p><offsets xml_i="13279" xml_f="13749" txt_i="7344" txt_f="7814">A total of 256 infants were considered eligible for the study from June 2008 to December 2009. Of these, 59 were excluded, 42 of them due to the fact that informed consent was not given on time, 10 because their CPAP did not become ready on time, and 7 because their parents refused to participate. Thus, a total of 197 patients were included in the study: 99 assigned to the routine group and 98 to the CPAP group. After inclusion, no infant was excluded from analysis.</offsets></p><p><offsets xml_i="13756" xml_f="13832" txt_i="7815" txt_f="7891">The antenatal conditions of the two groups were similar and are reported in </offsets><xref ref-type="table" rid="t01"><offsets xml_i="13865" xml_f="13872" txt_i="7891" txt_f="7898">Table 1</offsets></xref><offsets xml_i="13879" xml_f="13985" txt_i="7898" txt_f="8004">. There was a high occurrence of maternal hypertension and a low percentage of use of antenatal corticoid.</offsets></p><p><offsets xml_i="13992" xml_f="13993" txt_i="8005" txt_f="8006">
</offsets><table-wrap id="t01" orientation="portrait" position="float"><graphic xlink:href="1414-431X-bjmbr-47-03-00259-gt001"></graphic></table-wrap><offsets xml_i="14133" xml_f="14134" txt_i="8006" txt_f="8007">
</offsets></p><p><offsets xml_i="14141" xml_f="14225" txt_i="8008" txt_f="8092">The main birth characteristics of the infants included in the study are reported in </offsets><xref ref-type="table" rid="t02"><offsets xml_i="14258" xml_f="14265" txt_i="8092" txt_f="8099">Table 2</offsets></xref><offsets xml_i="14272" xml_f="14325" txt_i="8099" txt_f="8152">. There was no significant difference between groups.</offsets></p><p><offsets xml_i="14332" xml_f="14333" txt_i="8153" txt_f="8154">
</offsets><table-wrap id="t02" orientation="portrait" position="float"><graphic xlink:href="1414-431X-bjmbr-47-03-00259-gt002"></graphic></table-wrap><offsets xml_i="14473" xml_f="14474" txt_i="8154" txt_f="8155">
</offsets></p><p><offsets xml_i="14481" xml_f="14599" txt_i="8156" txt_f="8274">There was no difference between groups regarding the need for mechanical ventilation during the first 5 days of life (</offsets><xref ref-type="table" rid="t03"><offsets xml_i="14632" xml_f="14639" txt_i="8274" txt_f="8281">Table 3</offsets></xref><offsets xml_i="14646" xml_f="14867" txt_i="8281" txt_f="8502">). The CPAP group required a greater number of surfactant doses. Sixty percent of the infants submitted to routine treatment received CPAP due to clinical indication by the medical team at a median time of 30 min of life.</offsets></p><p><offsets xml_i="14874" xml_f="14875" txt_i="8503" txt_f="8504">
</offsets><table-wrap id="t03" orientation="portrait" position="float"><graphic xlink:href="1414-431X-bjmbr-47-03-00259-gt003"></graphic></table-wrap><offsets xml_i="15015" xml_f="15016" txt_i="8504" txt_f="8505">
</offsets></p><p><offsets xml_i="15023" xml_f="15253" txt_i="8506" txt_f="8736">There was no difference between the randomized infants during hospitalization regarding respiratory morbidity and mortality. The occurrence of apnea was high in both groups (33.6% in the CPAP group and 42.4% in the routine group).</offsets></p></sec><sec sec-type="discussion"><title><offsets xml_i="15297" xml_f="15307" txt_i="8738" txt_f="8748">Discussion</offsets></title><p><offsets xml_i="15318" xml_f="15497" txt_i="8749" txt_f="8928">Several alternatives have been proposed to minimize lung injury in preterm infants, one of them being the early application of CPAP, although there are doubts about its efficacy (</offsets><xref rid="B09" ref-type="bibr"><offsets xml_i="15529" xml_f="15530" txt_i="8928" txt_f="8929">9</offsets></xref><offsets xml_i="15537" xml_f="15538" txt_i="8929" txt_f="8930">-</offsets><xref rid="B12" ref-type="bibr"><offsets xml_i="15570" xml_f="15572" txt_i="8930" txt_f="8932">12</offsets></xref><offsets xml_i="15579" xml_f="15581" txt_i="8932" txt_f="8934">).</offsets></p><p><offsets xml_i="15588" xml_f="15681" txt_i="8935" txt_f="9028">The early CPAP system became a subject of study after a publication in 1987 by Avery et al. (</offsets><xref rid="B16" ref-type="bibr"><offsets xml_i="15713" xml_f="15715" txt_i="9028" txt_f="9030">16</offsets></xref><offsets xml_i="15722" xml_f="15940" txt_i="9030" txt_f="9248">) had shown a significantly lower incidence of the use of oxygen in newborns at 28 days at Columbia University compared to major American hospitals. The center in question differed from the others by using early CPAP (</offsets><xref rid="B16" ref-type="bibr"><offsets xml_i="15972" xml_f="15974" txt_i="9248" txt_f="9250">16</offsets></xref><offsets xml_i="15981" xml_f="15983" txt_i="9250" txt_f="9252">).</offsets></p><p><offsets xml_i="15990" xml_f="16486" txt_i="9253" txt_f="9749">The initial hypothesis of the present study was that, with early application of distention pressure, alveolar collapse would be reduced, with a consequent lower consumption of surfactant and a less frequent need for mechanical ventilation. However, in contrast to expectations, no significant difference was detected regarding the need for mechanical ventilation. In addition, the early CPAP group required a greater number of surfactant doses. Several factors may have influenced these findings.</offsets></p><p><offsets xml_i="16493" xml_f="16632" txt_i="9750" txt_f="9889">Although the maternal population of the preterm infants studied was comparable, these patients were at high obstetrical and neonatal risk (</offsets><xref ref-type="table" rid="t01"><offsets xml_i="16665" xml_f="16672" txt_i="9889" txt_f="9896">Table 1</offsets></xref><offsets xml_i="16679" xml_f="16857" txt_i="9896" txt_f="10074">). In this population, the incidence of gestational hypertension was high, about 45%, as opposed to values of 10 to 13% for all pregnancies reported in the Brazilian literature (</offsets><xref rid="B17" ref-type="bibr"><offsets xml_i="16889" xml_f="16891" txt_i="10074" txt_f="10076">17</offsets></xref><offsets xml_i="16898" xml_f="17293" txt_i="10076" txt_f="10471">). The occurrence of gestational hypertensive disease involves important perinatal implications such as prematurity, fetal growth restriction, and fetal distress. Although hypertension is believed to accelerate lung maturation, a study by the Brazilian Neonatal Network regarding risk factors for mortality in premature patients reported that hypertension was associated with the risk of death (</offsets><xref rid="B18" ref-type="bibr"><offsets xml_i="17325" xml_f="17327" txt_i="10471" txt_f="10473">18</offsets></xref><offsets xml_i="17334" xml_f="17336" txt_i="10473" txt_f="10475">).</offsets></p><p><offsets xml_i="17343" xml_f="17622" txt_i="10476" txt_f="10755">Also, the use of antenatal corticosteroid was low, occurring in about 65% of cases, despite more than 90% of the mothers having had at least two prenatal visits. In developed countries, antenatal corticosteroid is used in a much higher percentage of patients, usually above 80% (</offsets><xref rid="B09" ref-type="bibr"><offsets xml_i="17654" xml_f="17655" txt_i="10755" txt_f="10756">9</offsets></xref><offsets xml_i="17662" xml_f="17663" txt_i="10756" txt_f="10757">,</offsets><xref rid="B10" ref-type="bibr"><offsets xml_i="17695" xml_f="17697" txt_i="10757" txt_f="10759">10</offsets></xref><offsets xml_i="17704" xml_f="17980" txt_i="10759" txt_f="11035">). This fact is extremely relevant for the characterization of a population, because antenatal use of a corticosteroid proved to reduce the occurrence of respiratory distress syndrome, of peri- and intraventricular hemorrhage, and of neonatal mortality among preterm infants (</offsets><xref rid="B19" ref-type="bibr"><offsets xml_i="18012" xml_f="18014" txt_i="11035" txt_f="11037">19</offsets></xref><offsets xml_i="18021" xml_f="18112" txt_i="11037" txt_f="11128">). The lack of administration of an antenatal corticoid is a risk factor for CPAP failure (</offsets><xref rid="B20" ref-type="bibr"><offsets xml_i="18144" xml_f="18146" txt_i="11128" txt_f="11130">20</offsets></xref><offsets xml_i="18153" xml_f="18154" txt_i="11130" txt_f="11131">,</offsets><xref rid="B21" ref-type="bibr"><offsets xml_i="18186" xml_f="18188" txt_i="11131" txt_f="11133">21</offsets></xref><offsets xml_i="18195" xml_f="18197" txt_i="11133" txt_f="11135">).</offsets></p><p><offsets xml_i="18204" xml_f="18220" txt_i="11136" txt_f="11152">As presented in </offsets><xref ref-type="table" rid="t02"><offsets xml_i="18253" xml_f="18260" txt_i="11152" txt_f="11159">Table 2</offsets></xref><offsets xml_i="18267" xml_f="19149" txt_i="11159" txt_f="12041">, no significant differences among the characteristics of the neonates were detected. The patients presented optimal birth conditions, with a mean first-minute Apgar score of 6 and a fifth-minute score of 9, indicating sufficient conditions for the installation of the CPAP system in the delivery room. It is interesting to observe that approximately 45% of the patients required a balloon and mask ventilation before the installation of CPAP, and only 3.5% of the premature infants required intubation in the delivery room. In other words, almost one-half the infants of the CPAP group, who were supposed to receive the least possible detrimental ventilation, were previously submitted to bag ventilation, in which there is no control of the tidal volume or pressure offered. Despite the previous ventilation with bag and mask, it was possible to install CPAP in the delivery room.</offsets></p><p><offsets xml_i="19156" xml_f="19170" txt_i="12042" txt_f="12056">Finer et al. (</offsets><xref rid="B07" ref-type="bibr"><offsets xml_i="19202" xml_f="19203" txt_i="12056" txt_f="12057">7</offsets></xref><offsets xml_i="19210" xml_f="19644" txt_i="12057" txt_f="12491">) reported a 73% requirement of ventilation with positive pressure before the early installation of CPAP in a sample consisting of neonates born with less than 28 weeks of gestation and, among them, 49% of those selected for intervention required intubation in the delivery room. Before randomization, no statistical differences were observed. On the other hand, the random adjustment revealed six intubated infants in the CPAP group </offsets><italic><offsets xml_i="19652" xml_f="19654" txt_i="12491" txt_f="12493">vs</offsets></italic><offsets xml_i="19663" xml_f="19967" txt_i="12493" txt_f="12797"> one in the routine group, and the SNAPPE-II was two points higher in the CPAP group. These data may be indicative of a discrete greater clinical severity in the infants belonging to the CPAP group at selection. Prophylactic CPAP was also associated with a greater number of surfactant doses (median 1.5 </offsets><italic><offsets xml_i="19975" xml_f="19977" txt_i="12797" txt_f="12799">vs</offsets></italic><offsets xml_i="19986" xml_f="20353" txt_i="12799" txt_f="13166"> 1.0, P=0.02). The median time of administration of the first surfactant dose was also greater in the CPAP group, although the difference was not statistically significant. Perhaps postponing the time of administration of the first dose may have led to a worsening of the hyaline membrane situation, with the consequent need for a greater number of surfactant doses (</offsets><xref rid="B22" ref-type="bibr"><offsets xml_i="20385" xml_f="20387" txt_i="13166" txt_f="13168">22</offsets></xref><offsets xml_i="20394" xml_f="20880" txt_i="13168" txt_f="13654">). Therefore, the clinical significance of the differences should be considered. Another point that should be emphasized is that the use of CPAP occurred in 60% of cases in the routine group, whereas, obviously, it occurred in 100% of cases in the CPAP group. It is possible that 40% of the CPAP group unnecessarily received the pressure support. It has been reported that CPAP can also lead to injury, with a lower, but not negligible, potential than standard mechanical ventilation. (</offsets><xref rid="B04" ref-type="bibr"><offsets xml_i="20912" xml_f="20913" txt_i="13654" txt_f="13655">4</offsets></xref><offsets xml_i="20920" xml_f="21228" txt_i="13655" txt_f="13963">) Thus, applying CPAP prophylactically to patients before the installation of respiratory discomfort may have caused pulmonary inflammation and a consequent greater need for a surfactant. The discrete greater clinical severity of the CPAP group may also be, at least in part, responsible for the differences.</offsets></p><p><offsets xml_i="21235" xml_f="21310" txt_i="13964" txt_f="14039">CPAP was applied early to the routine group, with a median time of 30 min (</offsets><xref ref-type="table" rid="t03"><offsets xml_i="21343" xml_f="21350" txt_i="14039" txt_f="14046">Table 3</offsets></xref><offsets xml_i="21357" xml_f="21456" txt_i="14046" txt_f="14145">). The time of installation of prophylactic CPAP varies in the literature, with reports of 15 min (</offsets><xref rid="B05" ref-type="bibr"><offsets xml_i="21488" xml_f="21489" txt_i="14145" txt_f="14146">5</offsets></xref><offsets xml_i="21496" xml_f="21512" txt_i="14146" txt_f="14162">) or up to 2 h (</offsets><xref rid="B08" ref-type="bibr"><offsets xml_i="21544" xml_f="21545" txt_i="14162" txt_f="14163">8</offsets></xref><offsets xml_i="21552" xml_f="21853" txt_i="14163" txt_f="14464">). The early installation of CPAP in the routine group may have contributed to the occurrence of similar results in the two groups. These data suggest that perhaps it may not be necessary to install CPAP in the delivery room if there is the possibility of offering it early in the intensive care unit.</offsets></p><p><offsets xml_i="21860" xml_f="22233" txt_i="14465" txt_f="14838">Approximately 20% of the infants in both groups required mechanical ventilation during the first 5 days of life, with a median starting time of 135 min for the routine group and of 202 min for the CPAP group. These data are slightly worse than the 12% indication of mechanical ventilation found in the Italian population where about 83% received antenatal corticosteroids (</offsets><xref rid="B08" ref-type="bibr"><offsets xml_i="22265" xml_f="22266" txt_i="14838" txt_f="14839">8</offsets></xref><offsets xml_i="22273" xml_f="22530" txt_i="14839" txt_f="15096">). The application of CPAP during the first 15 min of life to infants from pregnancies with a high incidence of obstetrical disease and a low use of antenatal corticosteroid was not sufficient to modify the profile of ventilator assistance for the patients.</offsets></p><p><offsets xml_i="22537" xml_f="22579" txt_i="15097" txt_f="15139">The use of 2005 resuscitation guidelines (</offsets><xref rid="B13" ref-type="bibr"><offsets xml_i="22611" xml_f="22613" txt_i="15139" txt_f="15141">13</offsets></xref><offsets xml_i="22620" xml_f="22776" txt_i="15141" txt_f="15297">) can be considered a limitation of this study. It would be interesting to evaluate whether improved oxygen control recommended in the new 2010 guidelines (</offsets><xref rid="B23" ref-type="bibr"><offsets xml_i="22808" xml_f="22810" txt_i="15297" txt_f="15299">23</offsets></xref><offsets xml_i="22817" xml_f="22949" txt_i="15299" txt_f="15431">) would impact the results. However, studies on the subject conducted to date have used the same standards as in the present study (</offsets><xref rid="B07" ref-type="bibr"><offsets xml_i="22981" xml_f="22982" txt_i="15431" txt_f="15432">7</offsets></xref><offsets xml_i="22989" xml_f="22990" txt_i="15432" txt_f="15433">,</offsets><xref rid="B08" ref-type="bibr"><offsets xml_i="23022" xml_f="23023" txt_i="15433" txt_f="15434">8</offsets></xref><offsets xml_i="23030" xml_f="23031" txt_i="15434" txt_f="15435">,</offsets><xref rid="B11" ref-type="bibr"><offsets xml_i="23063" xml_f="23065" txt_i="15435" txt_f="15437">11</offsets></xref><offsets xml_i="23072" xml_f="23073" txt_i="15437" txt_f="15438">,</offsets><xref rid="B12" ref-type="bibr"><offsets xml_i="23105" xml_f="23107" txt_i="15438" txt_f="15440">12</offsets></xref><offsets xml_i="23114" xml_f="23679" txt_i="15440" txt_f="16005">), and controlling the supply of oxygen as recommended in the 2010 guidelines is unfortunately not yet a reality for all centers of neonatal assistance in developing countries. Another change in 2010 was the guideline for temperature control in premature infants, not recorded in this study, because we have no data on the temperature of the patients, which was another limitation of this study. Another limitation of the study was the time of application of CPAP in the routine group, which, as clinically indicated, ended up being very similar to the study group.</offsets></p><p><offsets xml_i="23686" xml_f="24137" txt_i="16006" txt_f="16457">Our new findings are that applying CPAP within the first 15 min of life in the delivery room causes the same effects as applying CPAP at 30 min in the neonatal unit. In conclusion, CPAP applied less than 15 min after birth was not able to reduce the need for ventilator support. It was associated with a higher number of doses of surfactant, when compared to CPAP applied as clinically indicated, with a median time of 30 min for 1000-1500 g newborns.</offsets></p></sec></body><back><ack><p>Research supported by FAPESP (#2006/61388-2).</p></ack><fn-group><fn fn-type="other"><p>First published online January 29, 2014.</p></fn></fn-group><ref-list><title>References</title><ref id="B01"><label>1</label><element-citation publication-type="webpage"><collab>Brazil</collab><ext-link ext-link-type="uri" xlink:href="http://www2.datasus.gov.br/DATASUS/index.php">http://www2.datasus.gov.br/DATASUS/index.php</ext-link></element-citation></ref><ref id="B02"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>MJ</given-names></name><name><surname>Probyn</surname><given-names>ME</given-names></name><name><surname>Zahra</surname><given-names>VA</given-names></name><name><surname>Crossley</surname><given-names>K</given-names></name><name><surname>Cole</surname><given-names>TJ</given-names></name><name><surname>Davis</surname><given-names>PG</given-names></name><etal></etal></person-group><article-title>Early biomarkers and potential mediators of ventilation-induced lung injury in very preterm lambs</article-title><source>Respir Res</source><year>2009</year><volume>10</volume><fpage>19</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1186/1465-9921-10-19</pub-id><pub-id pub-id-type="pmid">19284536</pub-id></element-citation></ref><ref id="B03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiswell</surname><given-names>TE</given-names></name></person-group><article-title>Resuscitation in the delivery room: lung protection from the first breath</article-title><source>Respir Care</source><year>2011</year><volume>56</volume><fpage>1360</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.4187/respcare.01433</pub-id><pub-id pub-id-type="pmid">21944685</pub-id></element-citation></ref><ref id="B04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jobe</surname><given-names>AH</given-names></name><name><surname>Kramer</surname><given-names>BW</given-names></name><name><surname>Moss</surname><given-names>TJ</given-names></name><name><surname>Newnham</surname><given-names>JP</given-names></name><name><surname>Ikegami</surname><given-names>M</given-names></name></person-group><article-title>Decreased indicators of lung injury with continuous positive expiratory pressure in preterm lambs</article-title><source>Pediatr Res</source><year>2002</year><volume>52</volume><fpage>387</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1203/00006450-200209000-00014</pub-id><pub-id pub-id-type="pmid">12193673</pub-id></element-citation></ref><ref id="B05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wung</surname><given-names>JT</given-names></name></person-group><article-title>Respiratory management for low-birth-weight infants</article-title><source>Crit Care Med</source><year>1993</year><volume>21</volume><fpage>S364</fpage><lpage>S365</lpage><pub-id pub-id-type="doi">10.1097/00003246-199309001-00040</pub-id><pub-id pub-id-type="pmid">8365229</pub-id></element-citation></ref><ref id="B06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas-Reyes</surname><given-names>MX</given-names></name><name><surname>Morley</surname><given-names>CJ</given-names></name><name><surname>Soll</surname><given-names>R</given-names></name></person-group><article-title>Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants</article-title><source>Cochrane Database Syst Rev</source><year>2012</year><volume>3</volume><elocation-id></elocation-id></element-citation></ref><ref id="B07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finer</surname><given-names>NN</given-names></name><name><surname>Carlo</surname><given-names>WA</given-names></name><name><surname>Duara</surname><given-names>S</given-names></name><name><surname>Fanaroff</surname><given-names>AA</given-names></name><name><surname>Donovan</surname><given-names>EF</given-names></name><name><surname>Wright</surname><given-names>LL</given-names></name><etal></etal></person-group><article-title>Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial</article-title><source>Pediatrics</source><year>2004</year><volume>114</volume><fpage>651</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1542/peds.2004-0394</pub-id><pub-id pub-id-type="pmid">15342835</pub-id></element-citation></ref><ref id="B08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandri</surname><given-names>F</given-names></name><name><surname>Ancora</surname><given-names>G</given-names></name><name><surname>Lanzoni</surname><given-names>A</given-names></name><name><surname>Tagliabue</surname><given-names>P</given-names></name><name><surname>Colnaghi</surname><given-names>M</given-names></name><name><surname>Ventura</surname><given-names>ML</given-names></name><etal></etal></person-group><article-title>Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial</article-title><source>Arch Dis Child Fetal Neonatal Ed</source><year>2004</year><volume>89</volume><fpage>F394</fpage><lpage>F398</lpage><pub-id pub-id-type="doi">10.1136/adc.2003.037010</pub-id><pub-id pub-id-type="pmid">15321956</pub-id></element-citation></ref><ref id="B09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandri</surname><given-names>F</given-names></name><name><surname>Plavka</surname><given-names>R</given-names></name><name><surname>Ancora</surname><given-names>G</given-names></name><name><surname>Simeoni</surname><given-names>U</given-names></name><name><surname>Stranak</surname><given-names>Z</given-names></name><name><surname>Martinelli</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Prophylactic or early selective surfactant combined with nCPAP in very preterm infants</article-title><source>Pediatrics</source><year>2010</year><volume>125</volume><fpage>e1402</fpage><lpage>e1409</lpage><pub-id pub-id-type="doi">10.1542/peds.2009-2131</pub-id><pub-id pub-id-type="pmid">20439601</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finer</surname><given-names>NN</given-names></name><name><surname>Carlo</surname><given-names>WA</given-names></name><name><surname>Walsh</surname><given-names>MC</given-names></name><name><surname>Rich</surname><given-names>W</given-names></name><name><surname>Gantz</surname><given-names>MG</given-names></name><name><surname>Laptook</surname><given-names>AR</given-names></name><etal></etal></person-group><article-title>Early CPAP versus surfactant in extremely preterm infants</article-title><source>N Engl J Med</source><year>2010</year><volume>362</volume><fpage>1970</fpage><lpage>1979</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0911783</pub-id><pub-id pub-id-type="pmid">20472939</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aly</surname><given-names>H</given-names></name><name><surname>Milner</surname><given-names>JD</given-names></name><name><surname>Patel</surname><given-names>K</given-names></name><name><surname>El-Mohandes</surname><given-names>AA</given-names></name></person-group><article-title>Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants?</article-title><source>Pediatrics</source><year>2004</year><volume>114</volume><fpage>697</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1542/peds.2003-0572-L</pub-id><pub-id pub-id-type="pmid">15342841</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirchner</surname><given-names>L</given-names></name><name><surname>Weninger</surname><given-names>M</given-names></name><name><surname>Unterasinger</surname><given-names>L</given-names></name><name><surname>Birnbacher</surname><given-names>R</given-names></name><name><surname>Hayde</surname><given-names>M</given-names></name><name><surname>Krepler</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>Is the use of early nasal CPAP associated with lower rates of chronic lung disease and retinopathy of prematurity? Nine years of experience with the Vermont Oxford Neonatal Network</article-title><source>J Perinat Med</source><year>2005</year><volume>33</volume><fpage>60</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1515/JPM.2005.010</pub-id><pub-id pub-id-type="pmid">15841616</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><article-title>2005 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: neonatal resuscitation guidelines</article-title><source>Pediatrics</source><year>2006</year><volume>117</volume><fpage>e1029</fpage><lpage>e1038</lpage><pub-id pub-id-type="doi">10.1542/peds.2006-0349</pub-id><pub-id pub-id-type="pmid">16651282</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>GR</given-names></name><name><surname>Himes</surname><given-names>JH</given-names></name><name><surname>Kaufman</surname><given-names>RB</given-names></name><name><surname>Mor</surname><given-names>J</given-names></name><name><surname>Kogan</surname><given-names>M</given-names></name></person-group><article-title>A United States national reference for fetal growth</article-title><source>Obstet Gynecol</source><year>1996</year><volume>87</volume><fpage>163</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/0029-7844(95)00386-X</pub-id><pub-id pub-id-type="pmid">8559516</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>DK</given-names></name><name><surname>Corcoran</surname><given-names>JD</given-names></name><name><surname>Escobar</surname><given-names>GJ</given-names></name><name><surname>Lee</surname><given-names>SK</given-names></name></person-group><article-title>SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores</article-title><source>J Pediatr</source><year>2001</year><volume>138</volume><fpage>92</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1067/mpd.2001.109608</pub-id><pub-id pub-id-type="pmid">11148519</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avery</surname><given-names>ME</given-names></name><name><surname>Tooley</surname><given-names>WH</given-names></name><name><surname>Keller</surname><given-names>JB</given-names></name><name><surname>Hurd</surname><given-names>SS</given-names></name><name><surname>Bryan</surname><given-names>MH</given-names></name><name><surname>Cotton</surname><given-names>RB</given-names></name><etal></etal></person-group><article-title>Is chronic lung disease in low birth weight infants preventable? A survey of eight centers</article-title><source>Pediatrics</source><year>1987</year><volume>79</volume><fpage>26</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">3797169</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaim S</surname><given-names>OS</given-names></name><name><surname>Kimura</surname><given-names>A</given-names></name></person-group><article-title>Pregnancy-induced hypertension and the neonatal outcome</article-title><source>Acta Paul Enferm</source><year>2008</year><volume>21</volume><fpage>6</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1590/S0103-21002008000100008</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>MF</given-names></name><name><surname>Guinsburg</surname><given-names>R</given-names></name><name><surname>Martinez</surname><given-names>FE</given-names></name><name><surname>Procianoy</surname><given-names>RS</given-names></name><name><surname>Leone</surname><given-names>CR</given-names></name><name><surname>Marba</surname><given-names>ST</given-names></name><etal></etal></person-group><article-title>Perinatal factors associated with early deaths of preterm infants born in Brazilian Network on Neonatal Research centers</article-title><source>J Pediatr</source><year>2008</year><volume>84</volume><fpage>300</fpage><lpage>307</lpage></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crowley</surname><given-names>P</given-names></name><name><surname>Chalmers</surname><given-names>I</given-names></name><name><surname>Keirse</surname><given-names>MJ</given-names></name></person-group><article-title>The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials</article-title><source>Br J Obstet Gynaecol</source><year>1990</year><volume>97</volume><fpage>11</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1111/j.1471-0528.1990.tb01711.x</pub-id><pub-id pub-id-type="pmid">2137711</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koti</surname><given-names>J</given-names></name><name><surname>Murki</surname><given-names>S</given-names></name><name><surname>Gaddam</surname><given-names>P</given-names></name><name><surname>Reddy</surname><given-names>A</given-names></name><name><surname>Reddy</surname><given-names>MD</given-names></name></person-group><article-title>Bubble CPAP for respiratory distress syndrome in preterm infants</article-title><source>Indian Pediatr</source><year>2010</year><volume>47</volume><fpage>139</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1007/s13312-010-0021-6</pub-id><pub-id pub-id-type="pmid">19578226</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boo</surname><given-names>NY</given-names></name><name><surname>Zuraidah</surname><given-names>AL</given-names></name><name><surname>Lim</surname><given-names>NL</given-names></name><name><surname>Zulfiqar</surname><given-names>MA</given-names></name></person-group><article-title>Predictors of failure of nasal continuous positive airway pressure in treatment of preterm infants with respiratory distress syndrome</article-title><source>J Trop Pediatr</source><year>2000</year><volume>46</volume><fpage>172</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1093/tropej/46.3.172</pub-id><pub-id pub-id-type="pmid">10893920</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="database"><person-group person-group-type="author"><name><surname>Yost</surname><given-names>CC</given-names></name><name><surname>Soll</surname><given-names>RF</given-names></name></person-group><article-title>Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome</article-title><source>Cochrane Database Syst Rev</source><year>2000</year><elocation-id></elocation-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlman</surname><given-names>JM</given-names></name><name><surname>Wyllie</surname><given-names>J</given-names></name><name><surname>Kattwinkel</surname><given-names>J</given-names></name><name><surname>Atkins</surname><given-names>DL</given-names></name><name><surname>Chameides</surname><given-names>L</given-names></name><name><surname>Goldsmith</surname><given-names>JP</given-names></name><etal></etal></person-group><article-title>Part 11: Neonatal resuscitation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations</article-title><source>Circulation</source><year>2010</year><volume>122</volume><fpage>S516</fpage><lpage>S538</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.971127</pub-id><pub-id pub-id-type="pmid">20956259</pub-id></element-citation></ref></ref-list></back></article>